Literature DB >> 1325728

Effects of uridine in the treatment of diabetic neuropathy: an electrophysiological study.

V Gallai1, G Mazzotta, S Montesi, P Sarchielli, F Del Gatto.   

Abstract

The authors performed a controlled double-blind neurophysiological study (uridine vs placebo) in 40 diabetic patients with peripheral neuropathy. Twenty subjects were treated with uridine and 20 with placebo. The neurophysiological evaluation consisted of a study of the MCV of the median nerve, the common Peroneal, the posterior Tibial, the SCV of the radial nerve, the median and the sural as well as the amplitudes of the motor and sensory responses. The nerves examined were on the dominant side. The evaluations were performed at baseline and after 60, 120, 180 days of therapy with a follow up control after 90 days from the completion of therapy. No statistically significant modifications were observed in the placebo group. In the drug group, the neurophysiological parameters improved significantly from the 120th day post therapy compared with baseline and were maintained through to follow up. The authors discuss the results which demonstrated that treatment with uridine can bring about a neurophysiological improvement in peripheral nerves.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325728     DOI: 10.1111/j.1600-0404.1992.tb08045.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  6 in total

Review 1.  FK506 and the role of immunophilins in nerve regeneration.

Authors:  B G Gold
Journal:  Mol Neurobiol       Date:  1997-12       Impact factor: 5.590

2.  Uridine metabolism in HIV-1-infected patients: effect of infection, of antiretroviral therapy and of HIV-1/ART-associated lipodystrophy syndrome.

Authors:  Pere Domingo; Javier Torres-Torronteras; Virginia Pomar; Marta Giralt; Joan Carles Domingo; Maria Del Mar Gutierrez; José M Gallego-Escuredo; Maria Gracia Mateo; Pedro Cano-Soldado; Irene Fernandez; Marçal Pastor-Anglada; Francesc Vidal; Francesc Villarroya; Antoni Andreu; Ramon Marti
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

3.  Chronic Uridine Administration Induces Fatty Liver and Pre-Diabetic Conditions in Mice.

Authors:  Yasuyo Urasaki; Giuseppe Pizzorno; Thuc T Le
Journal:  PLoS One       Date:  2016-01-20       Impact factor: 3.240

4.  A double-blind, randomized, comparative study of the use of a combination of uridine triphosphate trisodium, cytidine monophosphate disodium, and hydroxocobalamin, versus isolated treatment with hydroxocobalamin, in patients presenting with compressive neuralgias.

Authors:  Henrique Goldberg; Marco Antonio Mibielli; Carlos Pereira Nunes; Stephanie Wrobel Goldberg; Luiz Buchman; Spyros Ge Mezitis; Helio Rzetelna; Lisa Oliveira; Mauro Geller; Fernanda Wajnsztajn
Journal:  J Pain Res       Date:  2017-02-15       Impact factor: 3.133

Review 5.  Uridine Metabolism and Its Role in Glucose, Lipid, and Amino Acid Homeostasis.

Authors:  Yumei Zhang; Songge Guo; Chunyan Xie; Jun Fang
Journal:  Biomed Res Int       Date:  2020-04-14       Impact factor: 3.411

6.  Aging affects the biological activity of fibroblast growth factor (FGF) in gastric epithelial cell, which is partially rescued by uridine.

Authors:  Xiaomei Zhang; Huifeng Zhang; Jingli Gong; Huan Yu; Di Wu; Junyu Hou; Minghui Li; Xin Sun
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.